Skip to Main content Skip to Navigation
Journal articles

Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-02457059
Contributor : Isabelle Combe <>
Submitted on : Monday, January 27, 2020 - 5:41:43 PM
Last modification on : Wednesday, August 19, 2020 - 12:08:17 PM

Identifiers

Citation

Thomas Graillon, Marc Sanson, Chantal Campello, Ahmed Idbaih, Matthieu Peyre, et al.. Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial. Clinical Cancer Research, American Association for Cancer Research, 2020, ⟨10.1158/1078-0432.CCR-19-2109⟩. ⟨hal-02457059⟩

Share

Metrics

Record views

383